HighTide Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was CNY 939.31 million compared to CNY 190.24 million a year ago. Basic loss per share from continuing operations was CNY 3.62 compared to CNY 0.75 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.11 HKD | -3.40% | -3.77% | -60.57% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-60.57% | 336M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- 2511 Stock
- News HighTide Therapeutics, Inc.
- HighTide Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023